Assembly Biosciences, Inc.
ASMB
$30.82
$0.411.35%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 340.21% | 9.83% | -15.65% | 14.68% | -7.51% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -3.03% | 3.13% | -3.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -33.17% | 85.16% | 59.34% | -17.22% | 66.45% |
| Change in Net Operating Assets | -20.81% | 0.67% | 51.81% | -260.65% | 257.18% |
| Cash from Operations | 194.08% | 9.70% | 28.50% | -5,658.97% | 97.33% |
| Capital Expenditure | 42.86% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 113.43% | -1,031.09% | 158.03% | 198.36% | -127.34% |
| Cash from Investing | 113.41% | -1,031.33% | 158.03% | 198.36% | -127.34% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.73% | 48,060.22% | -81.43% | -88.69% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.73% | 48,060.22% | -81.43% | -88.69% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,539.95% | -348.23% | 103.97% | -250.94% | 7.01% |